We are shaping the future of cell and gene therapies
Our RNA platform allows us to engineer cells - and even remove unwanted cells - at bioreactor scale
Our RNA platform allows us to engineer cells - and even remove unwanted cells - at bioreactor scale
All the agility and benefits of mRNA, with none of the cons.
Long lasting stable expression, non-integrating and leave-no-trace, no batch transfections, simplified processes.
A seasoned bioinformatics specialist, Djordje combines his patient-centric industry knowledge with technical expertise and data-driven thinking to solve major challenges in stem cell therapies.
Mantas is an expert is synthetic biology and molecular cloning for advanced cell and gene therapies, having driven innovation in multiple biotech organisations, from startups to pharma.
Over a decade driving projects at leading PSC labs and biotechs has cemented Daniel as a world class stem cell biologist with deep knowledge of the challenges of cellular purity across many protocols.
Our board member Kerstin has extensive experience building, launching and supporting over a dozen biotechs in advanced cell and gene therapies.
Jeanette brings to our board her deep understanding of business development and deal making, developed over her two decades in cutting-edge biotech and big pharma.
A true pioneer and expert in the therapeutic cell manufacturing field, Ricardo combines extensive CMC and MSAT knowledge with quality and regulatory strategies.
As the former CEO of the Cell and Gene Therapy Catapult, Keith has been a driving force behind the development, commercialization and adoption of the cell and gene therapy industry across the UK.
Jonathan has decades of industrial scientific leadership experience, taking cutting-edge cell and gene therapies all the way to market.
